NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells

Immunology and Microbiology

• Prostate 100%
• Cell Proliferation 100%
• Cancer Cell 100%
• Xenograft 50%
• Drug Resistance 50%
• Cancer Mortality 50%
• Colony Formation 50%
• Cell Death 50%
• Protein Expression Level 50%
• Transcription Factors 50%
• Bioinformatics 50%
• Fibrinogen 50%
• Programmed Cell Death 50%

Medicine and Dentistry

• Cancer Cell 100%
• Prostate Cancer 100%
• Enzalutamide 100%
• Receptor Expression 18%
• Cell Proliferation 18%
• Androgen Receptor 18%
• Cancer Therapy 9%
• Clinical Study 9%
• Cancer Mortality 9%
• Xenograft 9%
• Tumor Progression 9%
• Programmed Cell Death 9%
• Protein Expression 9%
• Androgen Receptor Antagonist 9%
• Tumor 9%
• Colony Formation 9%
• Poly ADP Ribose Polymerase 9%
• Cell Death 9%
• Transcription Factors 9%
• Drug Resistance 9%
• Metalloproteinase 9%
• Fibrinogen 9%
• Diseases 9%
• Enzalutamide-Resistant Cell Line 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Enzalutamide 100%
• Prostate Cancer 100%
• Androgen Receptor 16%
• Clinical Study 8%
• Tumor Growth 8%
• Cancer Mortality 8%
• Androgen Receptor Antagonist 8%
• Transcription Factors 8%
• Drug Resistance 8%
• Metalloproteinase 8%
• Fibrinogen 8%
• Diseases 8%